Toxikon Corporation is a preclinical Contract Research Organization (CRO), with ISO/IEC 17025 accreditation that is registered with the US FDA and Japanese MHLW for drug and medical device testing. The Company provides in vivo, analytical, and in vitro testing services for the medical device, pharmaceutical and biotechnology sectors. Toxikon’s services include biocompatibility, surgical and ocular models, extractable & leachable (E&L), risk assessments, microbiology (cleaning, disinfection and sterilization validations), toxicology (including toxicity, genetic toxicology and carcinogenicity), PK, TK, ADME, chemical characterization, impurities analysis and synthesis and bioanalytical.
Toxikon was founded in 1982 and is headquartered in Bedford, MA. Toxikon’s laboratory facilities are fully accredited including GLP/GMP registrations, and the Bedford facilities have full USDA, OLAW, and AAALAC animal testing credentials. In addition, both facilities are ISO accredited, enabling GLP and non-GLP work across both facilities. The Company currently has approximately 80 animal rooms, and has extensive and fully equipped surgical suites, along with support services that include efficacy and research services, and histology and clinical pathology. The Company currently serves over 1,000 active customers across the medical device pharmaceutical, biotechnology sectors through-out the world.